The study says the two inactivated vaccines developed by Sinopharm prevented symptomatic infections by 72.8% & 78.1%, largely in-line with what the drugmaker previously announced.
Demand is expected to rise if WHO authorises China’s Sinovac & Sinopharm vaccines, allowing developing countries in Asia, Africa & Latin America to access them through Covax.
A notice issued to foreign journalists in Beijing Wednesday said they can get the Inactivated SARS-CoV-2 Vaccine, developed by Sinopharm's China National Biotec Group.
CanSino has applied for regulatory approval in Pakistan and will be give the country preferential access to the single-shot vaccine. Pakistan is yet to start its vaccination drive.
The vaccine has already been administered to hundreds of thousands of people under emergency authorization in China, but it’s yet to receive public use approval from any drug regulators.
New Delhi: The outsourcing industry, India’s largest white-collar employer, is a juggernaut that has all but stopped moving. The dollar revenue at the top...
By pairing Indian drone engineering with Japanese semiconductor expertise, the two firms aim to develop more advanced autonomous systems tailored to both defence & commercial use.
American objectives are unmet. They neither have muscle nor motivation to resume the war. As for Iran, the regime didn’t just survive, it’s now led by more radical individuals.
COMMENTS